Related Experiment Video
Updated: Apr 16, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Cost-constrained optimal sampling for system identification in pharmacokinetics applications with population priors
Carlos Oscars S Sorzano1, Maria Angeles Pérez-De-La-Cruz Moreno2, Jordi Burguet-Castell3
1Natl. Center of Biotechnology (CSIC), Madrid, Spain; KineStat Pharma, Madrid, Spain; Univ. San Pablo CEU, Madrid, Spain.
This study introduces an optimized irregular blood sampling strategy to personalize drug therapy by minimizing uncertainty in patient pharmacokinetic parameters. The method uses simulations and genetic algorithms for efficient, cost-constrained drug concentration monitoring.
Area of Science:
- Pharmacokinetics
- Systems Biology
- Computational Pharmacology
Background:
- Pharmacokinetic (PK) models represent complex nonlinear systems requiring accurate parameter estimation for personalized medicine.
- Population PK data exists, but individual patient parameter determination is crucial for tailored therapy.
- Current methods often involve frequent blood sampling, which can be costly and burdensome.
Purpose of the Study:
- To develop an irregular sampling strategy for pharmacokinetic (PK) system identification.
- To minimize uncertainty in PK parameters for individual patients under cost constraints.
- To enable personalized drug therapy through optimized drug concentration monitoring.
Main Methods:
- Utilized Monte Carlo simulations to estimate the average Fisher's information matrix for PK models.
- Employed a minimax criterion to identify sampling points that minimize maximum parameter uncertainty.
- Applied a genetic algorithm for optimizing the irregular sampling schedule.
Main Results:
- Demonstrated the design of an adaptive sampling scheme tailored to individual patients.
- Showcased the strategy's ability to accommodate various dosing regimens.
- Validated the approach for flexible therapeutic strategy development.
Conclusions:
- The proposed irregular sampling strategy effectively reduces uncertainty in patient-specific PK parameters.
- This method supports personalized medicine by optimizing drug monitoring.
- The approach offers a flexible and cost-effective solution for therapeutic drug management.
More Related Videos
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Dosage Regimens: Partial Pharmacokinetic Parameters
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.